FIRST 5th
Program
5th MEETING OF THE FORUM OF ITALIAN RESEARCHERS ON MESENCHYMAL AND STROMAL STEM CELLS (FIRST)
May 13th – 14th, 2013
Palazzo delle Stelline, Milano
Scientific Organizers: Lorenza Lazzari, Massimo Dominici, Rosaria Giordano
May 13th, 2013
h 9.00 - 10.00: Registration
h 9.45 – 10.00: Welcome by organizers
SESSION:
SESSION: IMMUNOLOGY
- h 10.00 – 10.20
“Platelet lysate expanded BMMSC for the treatment of steroid resistant grade III/IV aGVHD: results of the Monza-Bergamo phase I study” Martino Introna, Bergamo, Italy
- h 10.20 – 10.40
“Mesenchymal stromal key player in 'innate tolerance'?” Francesco Dazzi, London, UK
- h 10.40 – 11.15 Coffee time and Poster viewing
- h 11.30 – 12.30 Lecture
“Regulation of hematopoietic and mesenchymal stem cell migration and development in the murine bone marrow” Tsvee Lapidot, Rehovot, Israel
- h 12.30 – 14.30 Lunch break and Poster viewing
- h 14.30 – 15.30 Session: Young Researchers, FIRST Award (to be selected)
SESSION: BONE
- h 16.00 – 16.30
"Fostering endogenous bone repair using biological and physical cues". Georg N. Duda, Berlin, Germany
- h 16.30 – 17.00
“Bone regeneration and stem cell therapies. Reborne experience” Pierre Layrolle, Nantes, France
May 14th, 2013
SESSION: WHAT’S NEW?
- h 9.30 – 9.50
“Does stem cell differentiation really matter?“ Ornella Parolini, Brescia, Italy
- h 9.50 – 10.10
“Bioactive lipids and synthetic small molecules in stem cell biology” Luigi Anastasia, Milano, Italy
- h 10.10 – 10.30
“Reprogramming of adult somatic cells into other lineages: past evidence and future perspectives” Stefania Corti, Milano, Italy
- h 10.30 – 10.50
“Inhibition of platelet-derived growth factor receptor signaling regulates Oct4 and Nanog expression, cell shape, and mesenchymal stem cell potency” Cay Kielty, Manchester, UK
- h 10.50 – 11.30 Coffee time
SESSION: CLINICAL TRIALS
- h 11.30 – 11.50
“Human neural stem cell transplantation in amyotrophic lateral sclerosis” Angelo Vescovi, Terni, Italy
- h 11.50 – 12.10
“Clinical trials on adipose derived mesenchymal stem cells for fistulae” Damian Garcia-Olmo, Madrid, Spain
- h 12.30 Closing remarks
